Polypeptide-Functionalized Nanotubes for Implant Surface Modification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current implant technologies face challenges in promoting effective cell adhesion and tissue growth on their surfaces, particularly in orthopedic applications, where enhancing osteoblast adhesion and bone tissue formation are crucial for successful integration and regeneration.

Innovation Solution

The modification of implant surfaces with polypeptide-functionalized nanotubes that self-assemble into nanostructured architectures, such as rosette nanotubes, which include moieties that selectively promote the adhesion of osteoblasts and other cell types, thereby enhancing cell adhesion, proliferation, and differentiation, and facilitating tissue regeneration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If implant surfaces are modified with nanostructured coatings, then cell adhesion and tissue growth are promoted, but manufacturing complexity increases

Engineering Contradiction:
Improvecell adhesionVSAvoidmanufacturing complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent employs self-assembling peptide nanotubes that automatically organize into nanostructured coatings on implant surfaces without requiring complex external assembly processes. The peptides autonomously form the desired nanoscale architecture through spontaneous self-organization, eliminating the need for sophisticated manufacturing equipment or multi-step assembly procedures while achieving the target cell adhesion promotion.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent modifies surface properties by changing the chemical and physical parameters at the nanoscale level through peptide functionalization. By altering surface chemistry (adding specific amino acid sequences) and surface topology (creating nanotube structures with controlled diameter and spacing), the implant surface gains enhanced cell adhesion properties without fundamentally changing the bulk implant manufacturing process.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If polypeptide-functionalized nanotubes are used to selectively promote cell adhesion, then tissue regeneration is enhanced, but device complexity increases

Engineering Contradiction:
Improvetissue regenerationVSAvoiddevice complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent divides the complex function of tissue regeneration promotion into discrete functional segments within the peptide sequence. Specific amino acid motifs (such as RGD sequences for general adhesion, IKVAV for neural adhesion, and YIGSR for vascular adhesion) are segmented and incorporated into the nanotube structure, allowing selective promotion of different cell types through modular peptide design rather than requiring complex multi-component systems.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent creates composite functional structures by combining peptide molecules with nanotube architectures. The peptide-functionalized nanotubes represent a composite material system where the organic peptide layer provides biological functionality (cell selectivity) while the nanotube structure provides physical architecture, achieving enhanced tissue regeneration through material composition rather than complex device mechanisms.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The use of polypeptide-functionalized nanotubes significantly improves cell adhesion and tissue growth on implant surfaces, leading to enhanced osteoblast activity, bone tissue formation, and improved integration of implants, particularly in orthopedic applications.

Implementation Method 1

Modules of formula I and II self-assemble in water or aqueous solutions to produce discrete nanotubular assemblies

Methodology Applied
Scientific EffectSelf-assembly: Self-Assembly

Data Source

PatentUS10201634B2Nanotubes and compositions thereof
Publication Date: 2019.02.12 BROWN UNIVERSITY
  • US10201634B2 patent drawing
  • US10201634B2 patent drawing
  • US10201634B2 patent drawing

AI summary

The present invention is directed to implants and the modification of the surface of implants using amino acid or polypeptide functionalized rosette nanotubes.